Submit Your Paper Editorial Board Instructions for Authors Instructions for Reviewers Contact Us Editorial Policies Peer Review Archive

Director-in-Charge:
Prof. Khosro Adibkia

Editor-in-Chief:
Prof. Ali Shayanfar

Powered by:

January 2025, Vol 31, No. 1

Pharmaceutical Sciences is a peer-reviewed, and quarterly journal providing a forum for basic to clinical issues related to all areas of pharmaceutical sciences. It is the official journal of Faculty of Pharmacy, published by TUOMS PRESS, Tabriz University of Medical Sciences.
- Platinum Open Access (no processing or publication fees)
- Indexed in Web of Science Core Collection (Impact Factor 2023= 1.4) and Scopus (CiteScore 2023= 2.6)
- Average time to first decision in 2024 (all decisions): 15 days
- Time to first post-review decision in 2024: 2-8 weeks
- Acceptance rate in 2024: 10%
- Publications from 21 countries in 2024

Research Article

1. Expression Profile of LncRNAs in Childhood Acute Lymphoblastic Leukemia: A Pilot Study

Zohreh Mousavi, Saeid Ghorbian* , Azim Rezamand, Leyla Roshangar, Behboud Jafari

Pharm Sci. 2021;27(3): 385-392. doi: 10.34172/PS.2020.84

Scopus ID: 85115270040

Article

PDF

XML

Cited By:

Research Article

2. Evaluation of Methylation at Promoter Regions of Long Non-coding RNAs in Patients with Acute Lymphoblastic Leukemia

Zohreh Mousavi, Saeid Ghorbian* , Azim Rezamand, Leyla Roshangar, Behboud Jafari

Pharm Sci. 2021;27(4): 552-559. doi: 10.34172/PS.2021.18

Scopus ID: 85127175254

Article

PDF

XML

Cited By:

Research Article

3. EZH2 Knockdown Upregulates Expression of the Genes Involved in T-ALL Cell Differentiation

Sahar Safaei , Behzad Baradaran, Behzad Mansoori, Masoumeh Fardi , Elham Baghbani, Mohammad Amini, Nima Hemmat, Elham Safarzadeh, Mahdi Abdoli Shadbad, Dariush Shanehbandi, Saeed Solali*

Pharm Sci. 2022;28(3): 394-404. doi: 10.34172/PS.2021.56

Scopus ID: 85139857646

Article

PDF

XML

Cited By:

Research Article

4. Idarubicin versus Doxorubicin in Acute Myeloid Leukemia: A Parallel Randomized Trial with Pharmacoeconomic Analysis

Amany El Zeiny* , Raafat Abdel-Fattah, Maggie Abbassie, Samar Farid

Pharm Sci. 2024;30(1): 135-142. doi: 10.34172/PS.2023.28

Scopus ID: 85181565958

Article

PDF

XML

Cited By:

Research Article

5. Biogenic Zinc Oxide Nanoparticles Attenuate Acute Lymphoblastic Leukemia Cell Proliferation through Oxidative Stress and DNA Damage

Venugopal Sujatha* , Alagesan Venkatesan, Acharya Sancharan, Chinnasamy Thirunavukkarasu

Pharm Sci. 2024;30(2): 262-273. doi: 10.34172/PS.2024.4

Scopus ID: 85189473247

Article

PDF

XML

Cited By:

Research Article

6. Different Mitotic Arrest Targets of Chemoprevention Curcumin Analog 1.1 (CCA-1.1) and Pentagamavunone-1 (PGV-1) in Leukemic K-562 Cells

Riris Istighfari Jenie , Dhania Novitasari , Dyaningtyas Dewi Pamungkas Putri , Ratna Asmah Susidarti, Ikuko Nakamae, Noriko Yoneda-Kato, Jun-ya Kato , Edy Meiyanto*

Pharm Sci. 2025;31(1): 96-105. doi: 10.34172/PS.024.40438

Article

PDF

XML

Cited By:

Indexing & Abstracting:

Follow us on LinkedIn
Follow us on Twitter